- Raised $15M Series A led by Accelmed, Aug 2018
- Raised $8M Seed round led by Accelmed, Jun 2012
- Raised Secondary led by TechWald Holding, Oct 2023
About
Valcare Medical is dedicated to providing innovative minimally-invasive technologies for the treatment of mitral and tricuspid regurgitation. Its product line includes solutions for the repair and replacement of the mitral valve and repair of the tricuspid valve. The company's breakthrough mitral valve treatment platform is based on a D-shaped ring that serves as both a highly effective tool for mitral annulus repair and a docking station for Valcare's exclusive replacement prosthesis. They aim to eliminate the need for open-heart surgery in patients with severe mitral regurgitation, minimizing patient risk and maximizing procedural outcomes. Valcare Medical is also developing a transcatheter technology designed to offer treatment for mitral and tricuspid regurgitation. The company's flagship technology, the investigational AMEND™ Transcatheter Mitral Valve Repair Annuloplasty System, is designed to restore normal mitral valve geometry and function through a percutaneous approach.
Funding history · 3 rounds · $23.0M total
Headcount over time
Q&A
- What is ValCare Medical's primary focus?
- ValCare Medical develops minimally-invasive technologies for treating mitral and tricuspid regurgitation, including solutions for valve repair and replacement.
- When was ValCare Medical founded?
- ValCare Medical was founded in 2012.
- What is the status of ValCare Medical's AMEND™ TS EU Pilot Study?
- In May 2024, ValCare Medical announced the enrollment of the first two patients in its AMEND™ TS EU Pilot Study.
- Who is the CEO of ValCare Medical?
- Steve Sandweg was appointed CEO of ValCare Medical in April 2024, following a corporate restructuring.
- What is ValCare Medical's flagship technology?
- ValCare Medical's flagship technology is the investigational AMEND™ Transcatheter Mitral Valve Repair Annuloplasty System, designed to restore normal mitral valve geometry and function percutaneously.
- What was ValCare Medical's first funding round?
- ValCare Medical raised an $8 million A Round in July 2012, with Accelmed Ventures as a lead investor.
- What is the employee count for ValCare Medical?
- ValCare Medical has an employee count in the 11-50 range.
- What is the latest development regarding ValCare Medical's scientific advisory board?
- In July 2024, ValCare Medical, Inc. announced the formation of its Scientific Advisory Board, comprising renowned mitral valve experts.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | valcaremedical.com |
|---|---|
| linkedin.com/company/18263093 | |
| YouTube | youtube.com/channel/UCIZmvOtOceHOD8cWLpoYwyw |
Identifiers & details
| Founded | 2012 |
|---|---|
| Employees (exact) | 30 |
Radar intelligence
Patents
| EPO | 15 |
|---|
Web history (Wayback)
| Domain | valcaremedical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514791656 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2012-06-25 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 3 — annual_report (2), violation (1) |
| Registered address | משכית 2 הרצליה |
Recent registry events
| Date | Event |
|---|---|
| 2026-04-13 | דו~ח שנתי-עדכון מען דיגיטלי |
| 2026-04-13 | דו~ח שנתי-שינוי בהוראות בתקנון |
| 2026-06-07 | עדכון הפרה |